Quent Capital LLC Increases Stake in Cigna Group $CI

Quent Capital LLC grew its position in Cigna Group (NYSE:CI) by 6.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,252 shares of the health services provider’s stock after acquiring an additional 81 shares during the quarter. Quent Capital LLC’s holdings in Cigna Group were worth $414,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in CI. Nuveen LLC purchased a new stake in shares of Cigna Group in the first quarter valued at $727,905,000. Price T Rowe Associates Inc. MD raised its stake in shares of Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares during the period. GQG Partners LLC raised its stake in shares of Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after acquiring an additional 865,092 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after acquiring an additional 457,052 shares during the period. Finally, Bank of Nova Scotia raised its stake in shares of Cigna Group by 163.2% in the first quarter. Bank of Nova Scotia now owns 333,435 shares of the health services provider’s stock valued at $109,700,000 after acquiring an additional 206,739 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the topic of several recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $365.00 target price on shares of Cigna Group in a research note on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a “buy” rating in a report on Tuesday, August 5th. Royal Bank Of Canada restated an “outperform” rating and issued a $371.00 price target on shares of Cigna Group in a report on Thursday, June 26th. Barclays upped their price target on shares of Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Finally, Wells Fargo & Company cut their price target on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $371.81.

Cigna Group Stock Up 4.8%

NYSE:CI opened at $311.24 on Friday. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $358.88. The stock has a market capitalization of $83.08 billion, a P/E ratio of 16.99, a P/E/G ratio of 0.91 and a beta of 0.45. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company’s 50-day simple moving average is $292.41 and its 200-day simple moving average is $309.73.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same period last year, the business earned $6.72 EPS. The company’s revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.70% of the company’s stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.